Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Autoimmune Inflammation Increases Risk of Heart Disease

Susan Bernstein  |  Issue: January 2018  |  January 19, 2018

Alena Dutko / SHUTTERSTOCK.COM

Alena Dutko / SHUTTERSTOCK.COM

SAN DIEGO—It’s no secret: Autoimmune, inflammatory rheumatic disease raises a patient’s risk of cardiovascular disease (CVD).

“Inflammation may affect all aspects of the cardiac structure and function,” said Rekha Mankad, MD, FACC, director of the Women’s Heart Clinic at the Mayo Clinic in Rochester, Minn. Dr. Mankad also oversees a cardio-rheumatology clinic to assess and treat these complex patients. On Nov. 6 at the ACR/ARHP Annual Meeting, she discussed heart disease risk assessment and complications in rheumatic diseases. Rheumatoid arthritis patients have the highest CVD risk, followed by those with inflammatory bowel diseases.1 Survival rates are lower in RA patients due to heart disease.2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We see this risk in lupus as well. Rheumatologists have become incredibly good at treating lupus, so very active, early disease doesn’t take the lives of these patients, but as they live longer, heart disease is the reason for late deaths,” said Dr. Mankad.3 Ankylosing spondylitis patients may have higher rates of vas­cular death because AS often causes aortitis and aortic regurgitation.4 Lupus elevates a patient’s risk for pericardial effusion, which is often asymptomatic. Pericarditis usually happens during active lupus flares.

Valve Choice Matters

Antiphospholipid antibody syndrome, frequently seen in lupus, may cause valvular complications like Libman-Sacks endocarditis or nonbacterial thrombotic endocarditis (NBTE). Its bland lesions are filled with immune complexes, fibrin and platelet thrombi.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Why are these lesions important to recognize? Because you must figure out the right valve replacement choice. We are talking about a young patient population in lupus, women who are potentially in their childbearing years,” she said. Mechanical valves are preferable to bioprosthetic valves in this population, although it is important to carefully manage anticoagulation, especially if patients become pregnant.

Valve disease occurs in up to 20% of lupus patients and can worsen over time, she said. “This may be a population where we should be doing echocardiograms at baseline, although that’s not part of the guidelines.” Even healed lesions may lead to fibrosis later, she said.

Heart failure risk is also higher in RA.5 “As we age, everyone’s heart failure risk goes up, but if you have RA, that risk goes up dramatically,” she said. One study showed that RA patients’ inflammatory markers peaked six few months before their diagnoses.6 “This tells us that inflammation, which we know affects the joints and all parts of the body, certainly affects the myocardium and makes these patients more prone to heart failure.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting Reports Tagged with:ACR/ARHP Annual MeetingautoinflammatoryCardiovascular diseaseHeart Diseasepatient care

Related Articles

    Myositis & the Heart: New Perspectives on the Pathogenesis & Management of Cardiac Involvement in Myositis

    February 18, 2021

    Experts discuss the diagnosis and treatment of myositis-related cardiovascular disease.

    Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA

    July 15, 2017

    CHICAGO—Sherine E. Gabriel, MD, MSc, professor of medicine at Rutgers Medical School in Newark, N.J., and a past president of the ACR, presented an overview of cardiovascular disease and rheumatology on a Saturday morning to a room overflowing with rheumatologists attending the ACR’s State-of-the-Art Clinical Symposium in April. She noted that physicians have known for a…

    Heart to Heart: Cardiovascular Disease in Autoimmune Conditions

    December 2, 2021

    During the ACR Convergence 2021 Review Course, Joan Bathon, MD, discussed cardiovascular manifestations of autoimmune diseases, including rheumatoid arthritis.

    Updates on Managing Lupus Complications

    March 17, 2018

    SAN DIEGO—To manage patients with systemic lupus erythematous (SLE), rheuma­tologists must be aware of potentially serious complications affecting many organ systems. On Nov. 7 at the 2017 ACR/ARHP Annual Meeting, two experts offered insights on cardiovascular and hematological complications of lupus. Myocardial Disease in Lupus Lupus patients are at increased risk for heart-related complications, especially…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences